Safety and efficacy of DTG plus RPV in the phase III SWORD-1 and SWORD-2 studies: 48-week subgroup analysis by baseline third agent class and geographic locationC. Orkin,M-A Khuong-Josses,T. Lutz,D. Baker,R. Rubio,E. Blair,L. Kahl,K. Angelis,M. Underwood,B. Wynne, R. Shah,K. Vandermeulen,M. AboudHIV MEDICINE(2018)引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要